A major subset of patients with ankylosing spondylitis followed up in tertiary clinical care require anti-tumour necrosis factor alpha biological treatments according to the current guidelines - (:unkn) unknown (BMJ PUBLISHING GROUP, 2005)
Keywords: PLACEBO-CONTROLLED TRIAL; INFLIXIMAB; ARTHRITIS; EFFICACY; AGENTS; SAFETY